Liver diseases, including hepatitis, non-alcoholic fatty liver disease (NAFLD), cirrhosis, and hepatocellular carcinoma (HCC), remain a major global health concern, with early and accurate diagnosis ...

Premium is the first FDA-approved breast ultrasound supplemental screening technology specifically designed for detecting cancer in dense breasts SenoBright™ HD and SerenaBright™ are the first ...

EchoBack CAR T-cells are smart immune warriors that respond to ultrasound to fight cancer longer and more safely than ever before. They promise a big leap in treating solid tumors. Credit: ...

A new study uses DNA origami structures to selectively deliver fluorescent imaging agents to pancreatic cancer cells without affecting normal cells. The study, led by University of Illinois Urbana ...

Hepatocellular carcinoma (HCC) accounts for more than 90% of instances of liver cancer, which ranks as the fifth most frequent cancer in the United States. Furthermore, Texas leads the nation in the ...

The following is a summary of “Intraoperative Ultrasound-Guided Breast-Conserving Surgery: A Performance Analysis On The Basis Of Novel Cancer Lesion Classification And Patients’ Cosmetic Satisfaction ...

Her team set out to correct that situation by quantifying the number of cancers that stem from CT imaging. How Often Do CT Scans Lead to Cancer? Past research has also tried to measure just how ...

The FDA has granted full approval to Bristol Myers Squibb’s (BMS) dual immunotherapy regimen of Opdivo (nivolumab) plus Yervoy (ipilimumab) for adults with unresectable or metastatic hepatocellular ...

as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma (HCC). Median overall survival, the primary outcome measure, was 23.7 months in those randomized to ...